A total of 2,538 patients taking piperacillin/tazobactam and 1,134 patients taking levofloxacin were included in the analysis. NEW ORLEANS, LA—W. Cliff Rutter ...

The coadministration of piperacillin-tazobactam and vancomycin may raise the risk for AKI, according to a warning from the US Food and Drug Administration. The ACORN trial included 2511 adults ...

Piperacillin 2g, tazobactam 0.25g (2.25g vial); or piperacillin 3g, tazobactam 0.375g (3.375g vial); or piperacillin 4g, tazobactam 0.5g (4.5g vial); lyophilized pwd for IV inj after reconstitution; ...

Please provide your email address to receive an email when new articles are posted on . “In recent decades, these bacteria have become increasingly resistant to common antibiotics, such as penicillins ...

They found marked differences: treatment with piperacillin-tazobactam was associated with a 5 percent increase in 90-day mortality, more days on a ventilator, and more time with organ failure.

Princeton, New Jersey; October 21, 2010 - Sandoz today announced the launch of piperacillin and tazobactam for injection, a generic equivalent of Zosyn®, in the US. Piperacillin and tazobactam for ...

BETHLEHEM, Pa., Dec. 5, 2025 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, recently launched Piperacillin and Tazobactam, one of the most ...

About The Study: Among 2,511 adults hospitalized with acute infection, treatment with the antibiotic piperacillin-tazobactam did not increase the incidence of acute kidney injury or death in this ...

Madrid, Spain: The antibiotic combination treatment piperacillin-tazobactam was significantly less effective than meropenem when treating potentially fatal bloodstream infections (BSI) caused by ...